FDANews
www.fdanews.com/articles/192258-renalsense-earns-ce-mark-for-monitoring-system
RenalSense_Logo.png

RenalSense Earns CE Mark for Monitoring System

August 6, 2019

RenalSense has received the CE Mark for its Clarity RMS, a critical care monitoring platform that constantly measures a patient’s urine flow.

The device operates 24/7, transmitting real-time data related to changes in renal function and sending fluctuation alerts to medical staff automatically.

The information relayed by the device is used for early detection of acute kidney injury early to enable quick intervention.

View today's stories